{"id":"W4401805922","doi":"10.1007/s12185-024-03834-9","title":"Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study","year":2024,"lang":"en","type":"article","venue":"International Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Medicine; Internal medicine; Adverse effect; Cohort; Refractory (planetary science); Gastroenterology; Lymphoma; Oncology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001706884,0.0005192635,0.001446845,0.0002682942,0.0004565106,0.000743683,0.000277921,0.0005603047,0.0006261688],"category_scores_gemma":[0.0007371401,0.0003035696,0.001198719,0.0003640609,0.000371138,0.0004985288,0.0002502128,0.000884855,0.0002096811],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005817472,"about_ca_system_score_gemma":0.0007136763,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001309745,"about_ca_topic_score_gemma":0.002551261,"domain_scores_codex":[0.9996392,0.0001121013,0.00004165347,0.00006221906,0.00005567279,0.00008911209],"domain_scores_gemma":[0.9992243,0.00008745477,0.0002365252,0.00008111805,0.00008639378,0.0002841426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2001926,0.02443403,0.4266015,0.001549349,0.00879743,0.002951701,0.001497168,0.002836772,0.1010686,0.0001870256,0.003825272,0.2260586],"study_design_scores_gemma":[0.05461666,0.1673453,0.7547401,0.0001009584,0.005525947,0.002424857,0.0003587865,0.002173431,0.006092656,0.0001637142,0.006372179,0.00008545777],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966635,0.002129665,0.0002347021,0.00007078011,0.00001365877,0.0002425457,0.0002818801,0.00002088654,0.0003422544],"genre_scores_gemma":[0.9965521,0.0009220353,0.0003472716,0.0003773982,0.00003279532,0.0001986031,0.001200799,0.000007570576,0.0003613472],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001706884,"threshold_uncertainty_score":0.009026945,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01632198740253884,"score_gpt":0.3324388202306839,"score_spread":0.3161168328281451,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}